AstraZeneca sued in London over adverse events linked to COVID shot
Leon Neal

Legal cases have been filed in London over allegations that AstraZeneca's (NASDAQ:AZN) COVID-19 vaccine led to adverse events, including a death, two of potentially dozens of similar lawsuits against the U.K.-based company, Reuters reported Wednesday.
According to court records, a product liability claim was filed against the Anglo-Swedish pharma giant in London's High Court in early August by Anish Tailor, who says his wife Alpa died in March 2021 after receiving her first AstraZeneca (AZN) vaccine dose.
Peter Todd, who represents Tailor on behalf of the law firm Scott-Moncrieff & Associates, said that 50 other clients are waiting to file lawsuits against the company in the coming months.
During the pandemic, AstraZeneca (AZN) was among the frontrunners in the global vaccine race, with its two-dose COVID shot developed in partnership with the University of Oxford.
After introducing it in early 2021, the U.K. restricted its use among those under 40 due to rare events of blood clot formation.
Jamie Scott, who also filed a similar lawsuit against AstraZeneca (AZN) on Monday, claims he was diagnosed with thrombotic thrombocytopenia, a rare clotting disorder, after receiving the vaccine.

AstraZeneca (AZN) refused to comment on ongoing legal cases. "Patient safety is our highest priority, and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines," Reuters reported, quoting a company spokesperson.
More on AstraZeneca

AstraZeneca: Robust Performance And Promising Growth Initiatives
AstraZeneca's Q2 Earnings Exceed Expectations, Astonishing Investors (Rating Upgrade)
AstraZeneca: Solid Earnings Report Reinforces Medium To Long-Term Upside
AstraZeneca inks mRNA vaccine deal with China's CanSino
AstraZeneca, Sanofi RSV treatment Beyfortus endorsed by CDC panel (updated)